Tesla Just Delivered Excellent News, but Is the Stock a Buy?

Tesla’s EV deliveries rose 16% year over year to 838,149 in the first half of 2026, but Q3 deliveries fell 2% to 486,532 despite beating the 461,974 consensus estimate. The article says price cuts and competition are pressuring profitability: trailing-four-quarter EPS was $1.08, down 75% over two years, while the stock traded at a 343 P/E versus 35.2 for the Nasdaq-100. It argues that pulling the Model S and Model X to repurpose production lines for Optimus, alongside the unscaled and unapproved Cybercab, leaves the valuation vulnerable.

Analysis

The key distinction is volume versus economic recovery: delivery growth driven by price reductions can support factory utilization while still weakening revenue per vehicle and earnings quality. Higher oil prices are a sector tailwind, not a Tesla-specific moat; if they ease, demand may require further discounting. The October 21 results should therefore be judged on automotive pricing, margins, inventory and cash generation—not the delivery beat alone.

The premium-model production shift creates a potential opening for BMW and Mercedes-Benz in higher-end EVs, but it is not evidence that Tesla is exiting passenger EVs. The larger second-order risk is opportunity cost: redirecting capacity and engineering attention toward Cybercab and Optimus may slow EV cost and product competitiveness before either new platform contributes at scale. Optimus also introduces execution and potential capital-intensity risk; autonomy adds a distinct regulatory gate. Alphabet’s operating position in robotaxis raises the bar for Tesla’s commercialization, though it does not establish that Tesla cannot catch up.

Near term, delivery-related optimism can persist; the October earnings release is the next test of whether sales translate into profit. Over 1–3 months, margin deterioration or weaker guidance could challenge the valuation, while stable margins would weaken the bearish case. Over 6–18 months, regulatory approvals and evidence of repeatable robotaxi or robot deployments matter more than aspirational market-size claims. The contrarian risk to a short is that investors value Tesla as a technology option, not an automaker: that optionality can keep the stock expensive even if vehicle economics remain pressured.

Key Decisions for Investors

• Keep TSLA underweight rather than making an unhedged, open-ended short: the downside case is deteriorating vehicle economics, but the embedded autonomy/robotics option creates material squeeze risk.
• Treat October 21 as a verification catalyst. Track automotive gross margin excluding credits, average selling prices, inventory and cash generation; improving deliveries without stabilization in these measures would support the bearish thesis. Margin recovery without renewed discounting would falsify it.
• For defined-risk bearish exposure, consider a TSLA put spread only if pre-event implied volatility is not pricing an excessive move; otherwise wait for the earnings reaction. No price target or options-premium data is provided, so size and strikes require current market data.
• Monitor BMW and Mercedes-Benz for evidence that premium-EV demand or share is actually accruing to them before expressing a long-versus-TSLA pair. The article provides no comparative sales, margins or valuation data to justify that pair today.
• Reassess the structural discount thesis if Tesla secures relevant unsupervised-driving approvals and demonstrates repeatable commercial deployments, or if Optimus produces verifiable customer demand and unit economics; announcements and long-range revenue aspirations alone are insufficient.